PCOS is Now PMOS: Understanding the Name Change
ASRM has endorsed the name change for the condition previously known as Polycystic Ovary Syndrome (PCOS). The new name is Polyendocrine Metabolic Ovarian Syndrome (PMOS). PMOS impacts 1 in 8 women, which equates to more than 170 million women worldwide. For too long, PCOS has been reduced from a complex, long-term hormonal or endocrine disorder to a misunderstanding about ‘cysts’ and a focus on ovaries. This contributed to missed diagnoses and inadequate treatment.
The new name was developed through a global engagement that included 56 patient organizations and societies worldwide, including ASRM. The work included a survey with 22,000 responses and the performance of multiple workshops of health care professionals and women with lived experience.
Women with the condition were the biggest drivers of the name change.
The new name, PMOS, accurately reflects the condition and its symptoms. The name change will facilitate greater awareness, improving care and outcomes.
For resources in multiple languages, visit this website
The new name was developed through a global engagement that included 56 patient organizations and societies worldwide, including ASRM. The work included a survey with 22,000 responses and the performance of multiple workshops of health care professionals and women with lived experience.
Women with the condition were the biggest drivers of the name change.
The new name, PMOS, accurately reflects the condition and its symptoms. The name change will facilitate greater awareness, improving care and outcomes.
For resources in multiple languages, visit this website
Fertility in the News
ASRM Physician Members Warn State Reporting Bills Could Turn Fertility Care Into a Political Target
ASRM warns state IVF reporting bills could threaten patient privacy, fertility care, and access by replacing medical expertise with political oversight.
ASRM Center for Policy and Leadership Sponsors Petrie-Flom Center’s Annual Conference on Embryo Law and Ethics at Harvard Law School
ASRM and Harvard Law School convene experts to explore IVF policy, embryo law, personhood, AI-selected embryos, and reproductive ethics after Dobbs.FIND AN EXPERT
Coping with hirsutism and PMOS (formerly known as PCOS) can be emotionally challenging. You may feel self-conscious or concerned about issues like excessive hair growth, weight management, or future fertility. It’s important to remember that many people experience similar challenges, and these conditions are more common than you might think. Seeking support early on can make a difference, as early diagnosis and treatment often lead to better outcomes.
Even though you may feel hesitant to share these feelings, talking with a physician can open doors to medical and cosmetic treatments that address both PMOS and hirsutism. A range of options is available, including medication, and, if needed, electrolysis or laser treatments to permanently reduce unwanted hair.
If you’re seeking specialized help, ASRM can assist in finding a reproductive endocrinologist knowledgeable about Polyendocrine Metabolic Ovarian Syndrome (PMOS). This specialist can guide you on your journey and help you address your specific goals and concerns.
Search for an Expert